HomeVICO • STO
add
Vicore Pharma Holding AB
Previous close
kr 9.30
Day range
kr 9.20 - kr 9.51
Year range
kr 6.92 - kr 23.45
Market cap
2.18B SEK
Avg Volume
621.14K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 60.34M | -7.77% |
Net income | -59.95M | 5.69% |
Net profit margin | — | — |
Earnings per share | -0.54 | 6.90% |
EBITDA | -59.78M | -13.68% |
Effective tax rate | 0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 380.42M | -31.02% |
Total assets | 406.90M | -33.57% |
Total liabilities | 29.16M | -36.69% |
Total equity | 377.74M | — |
Shares outstanding | 111.73M | — |
Price to book | 2.75 | — |
Return on assets | -34.07% | — |
Return on capital | -37.13% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -59.95M | 5.69% |
Cash from operations | -87.30M | -146.86% |
Cash from investing | 68.61M | 134.47% |
Cash from financing | — | — |
Net change in cash | -22.03M | -124.08% |
Free cash flow | -64.10M | -470.14% |
About
Founded
2000
Website
Employees
29
